A medication list is not a finished handover
An owner’s perspective on making medication information accountable between care settings.
As the owner of PRIS Care, I want to ask a practical question about clinic workflows: when a medication list arrives, who owns the next step? Receiving a document is an event. Establishing what it means for the next appointment is a responsibility. I believe that distinction deserves more attention than the number of files successfully sent.
Start with the limits of the evidence
England’s Care Quality Commission published its 2025 adult inpatient survey in August 2026. Asked about medicines to take at home, 51% reported an explanation of their purpose, 42% an explanation of how to take them, 34% written information and 20% an explanation of side effects.
These percentages use everyone answering that question, including those reporting no medicine. People could select several answers. They are patient-reported information measures—not medication-error rates or a reconciliation audit. The evidence describes England, not every UK nation or the United States. For me, it raises a practical question: how does a clinic know which information still needs a professional’s attention?
England: information about medicines to take at home
CQC Adult inpatient survey 2025, question 39
Percentage of respondents answering Q39
Make the handover a defined piece of work
NICE’s medicines-optimisation guidance distinguishes gathering an accurate medicines list from comparing records, identifying discrepancies and documenting changes. It calls for clear responsibilities when information moves between providers. In the United States, AHRQ’s MATCH toolkit similarly treats reconciliation as a process at admission, transfer and discharge. These are established resources, not new 2026 findings; local clinical policies still matter.
My proposed management starting point is a short process map: information received, routed to an appropriate professional, reviewed, and handed onward. At each step, the team should be able to identify the responsible role and the route for an unresolved question. An uploaded attachment should not silently count as a completed review.
Consider a hypothetical clinic appointment following a hospital discharge. The clinic has a discharge document, an existing record and a patient’s account. The administrative question is not which version should win. It is whether the right professional can see that a comparison is needed, knows where the relevant information is, and has a clear way to record the outcome. Clinical interpretation belongs with qualified professionals, not an automated administrative decision.
Measure the work without overstating the result
I would begin with a small, locally agreed workflow check: among relevant incoming transitions, how many have an identified reviewer, a recorded review status and a documented next step for unresolved information? Keep these as separate measures. A named reviewer is not proof that a discrepancy has been resolved, and a completed field is not evidence of reduced harm.
The useful discussion is about ownership, not blame. Where does a question wait? Who can see it? What tells the receiving team that work is still outstanding? Answers should improve the process without asking patients to become its sole coordinators.
If you manage or work in a clinic, the PRIS clinic survey is an invitation to share where handovers create uncertainty. Please describe the workflow, not identifiable patient details. Listening carefully is a sensible place to start.
Related: reviewing antibiotic prescribing
Share your clinic’s workflow priorities